Related Experiment Videos
Late recurrence of seminoma
C D Blanke1, S C Delgalvis, G R Nichols
1Department of Medicine, Vanderbilt University Medical Center, Nashville, Tenn, USA.
Southern Medical Journal
|June 1, 1997
Summary
Testicular cancer seminoma can recur decades after treatment, challenging the 2-year cure assumption. This case highlights the need for lifelong surveillance in germ cell cancer survivors.
Area of Science:
- Oncology
- Urology
- Cancer Research
Background:
- Testicular cancer, particularly germ cell tumors, is often considered curable with a high survival rate after 2 years of disease-free follow-up.
- Late recurrences, occurring more than 2 years post-treatment, are uncommon but have been reported in germ cell cancer survivors.
Observation:
- A patient with documented seminoma experienced recurrence 21 years post-orchiectomy.
- A second recurrence was documented 32 years after the initial orchiectomy.
- This case highlights exceptionally late relapse patterns in testicular cancer.
Findings:
- Seminoma can recur decades after initial treatment and apparent cure.
- The 2-year disease-free survival benchmark may not encompass all potential relapse timelines for germ cell cancers.
- Late recurrences suggest complex biological mechanisms or prolonged dormancy.
Implications:
- Lifelong surveillance may be warranted for testicular cancer survivors to detect very late recurrences.
- Re-evaluation of long-term follow-up protocols for germ cell tumor patients is needed.
- Understanding mechanisms of late recurrence can inform future treatment and monitoring strategies.